NASDAQ$GBIO

Generation Bio Co · Q2 2019 earnings

Q2 2019 earnings · · Investor relations

Headline financials

EPS (adj)

-$0.48

No prior period
Weighted average common shares outstanding

4.6M

No prior period
Net Income

-$15M

No prior period
Operating Income

-$15.3M

No prior period
Gross Profit

$0.00

No prior period
R&D Expense

$12.2M

No prior period

Revenue & EPS history

Generation Bio · Revenue · Quarterly

$1.59M

Q3 2025-78.9%vs Q3 2024
Beat estimate in 7 of 10 quarters(70%)
ActualEstimate

Revenue by segment

Generation Bio · $2.15M total across 1 segment · Q3 2023

  • Collaboration revenue
    $2.15M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports

Historical avg

+3.8%

Avg return

Earnings day

+5.9%

Avg return

5 days after

+8.6%

Avg return

30 days after

43%

10 / 23 earnings

Positive

+61.7%

Q2 2025

Best reaction

-19.7%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025-3.3%+11.0%+2.7%
Q2 2025+61.7%+62.0%+46.9%
Q1 2025+4.5%+0.4%+4.0%
Q4 2024-3.7%-14.3%-9.5%
Q3 2024+8.7%-0.5%-40.8%
Q2 2024-2.0%-3.7%-10.2%
Q1 2024+18.4%+16.4%+1.9%
Q4 2023+3.1%+11.5%+39.4%
Q3 2023-1.7%+7.7%+46.2%
Q2 2023-5.3%-7.0%+6.8%
Q1 2023-5.0%-2.7%+0.4%
Q4 2022-8.4%-10.0%+15.5%
Q3 2022+12.2%
Q2 2022+7.7%
Q1 2022-19.7%
Q4 2021+21.1%
Q3 2021-1.5%
Q2 2021-6.2%
Q1 2021+0.3%
Q4 2020-0.9%
Q3 2020+8.5%
Q4 2019-0.5%
Q2 2020-0.5%
Q1 2020
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro